Full Text

Turn on search term navigation

© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

Preterm birth remains an important cause of abnormal neurodevelopment. While the majority of preterm infants are born moderate-late preterm (MLPT; 32–36 weeks), international and national recommendations on neurological surveillance in this population are lacking. We conducted an observational quantitative survey among Dutch and Canadian neonatal level I–III centres (June 2020–August 2021) to gain insight into local clinical practices on neurological surveillance in MLPT infants. All centres caring for MLPT infants designated one paediatrician/neonatologist to complete the survey. A total of 85 out of 174 (49%) qualifying neonatal centres completed the survey (60 level I–II and 25 level III centres). Admission of MLPT infants was based on infant-related criteria in 78/85 (92%) centres. Cranial ultrasonography to screen the infant’s brain for abnormalities was routinely performed in 16/85 (19%) centres, while only on indication in 39/85 (46%). In 57/85 (67%) centres, neurological examination was performed at least once during admission. Of 85 centres, 51 (60%) followed the infants’ development post-discharge, with follow-up duration ranging from 1–52 months of age. The survey showed a wide variety in neurological surveillance in MLPT infants among Dutch and Canadian neonatal centres. Given the risk for short-term morbidity and long-term neurodevelopmental disabilities, future studies are required to investigate best practices for in-hospital care and follow-up of MLPT infants.

Details

Title
Neurological Surveillance in Moderate-Late Preterm Infants—Results from a Dutch–Canadian Survey
Author
Krüse-Ruijter, Martine F 1 ; Boswinkel, Vivian 1   VIAFID ORCID Logo  ; Consoli, Anna 2 ; Nijholt, Ingrid M 3   VIAFID ORCID Logo  ; Boomsma, Martijn F 4 ; de Vries, Linda S 5 ; Gerda van Wezel-Meijler 1   VIAFID ORCID Logo  ; Leijser, Lara M 2   VIAFID ORCID Logo 

 Department of Neonatology, Isala Women and Children’s Hospital, 8025 AB Zwolle, The Netherlands; [email protected] (M.F.K.-R.); [email protected] (V.B.); [email protected] (G.v.W.-M.) 
 Section of Neonatology, Department of Pediatrics, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada; [email protected] 
 Department of Innovation & Science, Isala Hospital, 8025 AB Zwolle, The Netherlands; [email protected]; Department of Radiology, Isala Hospital, 8025 AB Zwolle, The Netherlands; [email protected] 
 Department of Radiology, Isala Hospital, 8025 AB Zwolle, The Netherlands; [email protected] 
 Department of Neonatology, University Medical Center, 3584 EA Utrecht, The Netherlands; [email protected] 
First page
846
Publication year
2022
Publication date
2022
Publisher
MDPI AG
e-ISSN
22279067
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2679689343
Copyright
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.